Federated Hermes
FBIO icon

Federated Hermes’s Fortress Biotech FBIO Stock Holding History

Federated Hermes’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,261
Closed -$3.52K – 2084
2026
Q1 		$3.52K Buy
+1,261
New +$4.29K ﹤0.01% 1928
2024
Q4 		– Sell
-263
Closed -$380 – 2114
2024
Q3 		$380 Buy
+263
New +$501 ﹤0.01% 2006
2020
Q4 		– Sell
-684
Closed -$41K – 2260
2020
Q3 		$41K Buy
+684
New +$34.8K ﹤0.01% 1811
2017
Q4 		– Sell
-122
Closed -$8K – 2195
2017
Q3 		$8K Hold
122
– – ﹤0.01% 1878
2017
Q2 		$9K Buy
+122
New +$7.2K ﹤0.01% 1854

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Federated Hermes's FBIO Position: Q2 2026 in Review

Federated Hermes sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 1,261 shares — an estimated $3.52K sold.

Federated Hermes first reported a position in FBIO in Q2 2017 and held it in 5 quarters. The position peaked at $41K in Q3 2020. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Federated Hermes reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 1,261 Fortress Biotech shares in Q2 2026, an estimated $3.52K.
  • Federated Hermes first reported a position in Fortress Biotech in Q2 2017 and held it in 5 quarters.
  • Federated Hermes's Fortress Biotech position peaked at $41K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.